1.15|0.72|7.43
委比:--
委差:--
卖五 | -- | -- |
卖四 | -- | -- |
卖三 | -- | -- |
卖二 | -- | -- |
卖一 | -- | -- |
买一 | -- | -- |
买二 | -- | -- |
买三 | -- | -- |
买四 | -- | -- |
买五 | -- | -- |
总流入:--万元
总流出:--万元
净 额:--万元
近5日内该股资金总体呈流出状态,低于行业平均水平,5日共流出-1205.23万元。
近5日内该股资金总体呈流出状态,低于行业平均水平,5日共流出-1205.23万元。
据统计,主力筹码比10日前集中,现在已低度控盘,投资者可关注。
公司简介
- 所属地域:
- 湖北省
- 涉及概念:
- 辅助生殖,融资融券,生物医药
- 主营业务:
- 经营分析
- 医药科技开发和技术服务;医药原料药及中间体生...
- 上市日期:
- 2021-04-09
- 每股净资产:
- 7.43元
- 每股收益:
- 0.20元
- 净利润:
- 0.23亿元
- 净利润增长率:
- -42.92%
- 营业收入:
- 3.85亿元
- 每股现金流:
- 0.08元
- 每股公积金:
- 3.57元
- 每股未分配利润:
- 2.78元
- 总股本:
- 1.15亿
- 流通股:
- 0.72亿
单位:万元
{"year":[2023,2022],"s03":[402.44,""],"s06":[1747.2,2698.07],"s09":[2278.45,3991.75],"s12":["",4018.77]}
同行业市场表现排行
3.7
综合判断:3.7分
打败了17%的股票!
短期趋势:
弱势下跌过程中,可逢高卖出,暂不考虑买进。
长期趋势:
已有23家主力机构披露2023-12-31报告期持股数据,持仓量总计16.50万股,占流通A股0.28%
近期的平均成本为14.65元。该股资金方面呈流出状态,投资者请谨慎投资。该公司运营状况尚可,多数机构认为该股长期投资价值较高,投资者可加强关注。 [诊断日期:2024年04月18日 16:56]
技术面诊股1.90
资金面诊股4.10
消息面诊股5.00
行业面诊股1.40
基本面诊股5.60
最近60个交易日,机构评级以增持为主,认为该股票有一定投资价值。
研究机构 |
评级日期 |
最新评级 |
上次评级 |
太平洋证券 |
2024-04-11 |
增持 |
|
该股2023年每股收益与前一年相同,长期投资价值一般。
[{"date":"2019","yellowRectValue":"0.73","blueLineValue":"","type":""},{"date":"2020","yellowRectValue":"0.53","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"0.78","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.40","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.22","blueLineValue":"0.19","type":"YC"}]
查看历史大宗交易信息>>
交易日期 |
成交价(元) |
成交金额(万元) |
成交量(万股) |
溢价率 |
买入营业部 |
卖出营业部 |
2024-04-18 |
12.13 |
200.15 |
16.50 |
-16.29% |
中国银河证券股份有限公司襄阳证券营业部 |
太平洋证券股份有限公司襄阳朝阳路证券营业部 |
融资融券
查看历史融资融券信息>>
融资余额若长期增加时表示投资者心态偏向买方,市场人气旺盛属强势市场;反之则属弱势市场。
交易日期 |
融资余额(亿元) |
融资余额/流通市值 |
融资买入额(亿元) |
融券卖出量(万股) |
融券余量(万股) |
融券余额(万元) |
融资融券余额(亿元) |
2024-04-17 |
0.620
|
5.81%
|
0.010
|
0.00 |
0.77 |
11.47 |
0.621
|
2024-04-16 |
0.630
|
6.39%
|
0.011
|
0.00 |
0.80 |
11.00 |
0.631
|
2024-04-15 |
0.644
|
6.01%
|
0.017
|
0.02 |
0.80 |
11.97 |
0.645
|
2024-04-12 |
0.646
|
5.54%
|
0.027
|
0.00 |
0.78 |
12.69 |
0.647
|
2024-04-11 |
0.636
|
5.49%
|
0.015
|
0.00 |
0.78 |
12.61 |
0.637
|
2024-04-10 |
0.636
|
5.45%
|
0.013
|
0.04 |
0.78 |
12.71 |
0.638
|
2024-04-09 |
0.644
|
5.28%
|
0.019
|
0.23 |
0.74 |
12.61 |
0.646
|
2024-04-08 |
0.659
|
7.00%
|
0.043
|
0.05 |
0.57 |
9.09 |
0.660
|
2024-04-03 |
0.662
|
6.46%
|
0.058
|
0.23 |
0.76 |
13.18 |
0.663
|
2024-04-02 |
0.657
|
6.46%
|
0.012
|
0.00 |
0.53 |
9.12 |
0.658
|
|
拓新药业 |
丽珠集团 |
力生制药 |
共同药业 |
摊薄每股收益 |
2.49 |
2.10 |
1.97 |
0.20 |
行业排名 |
1 |
2 |
3 |
89 |
[["2023-09-30","2278.45","0.20"],["2023-06-30","1747.20","0.15"],["2023-03-31","402.44","0.03"],["2022-12-31","4018.77","0.35"],["2022-09-30","3991.75","0.35"]]
[["\u62d3\u65b0\u836f\u4e1a","2.49"],["\u4e3d\u73e0\u96c6\u56e2","2.10"],["\u529b\u751f\u5236\u836f","1.97"],["\u5171\u540c\u836f\u4e1a","0.20"]]|88
300966
深证成指
399001
sz
1140
共同药业
[{"date":"20240320","item0":"0.12","item1":"1.32"},{"date":"20240321","item0":"-0.64","item1":"-1.09"},{"date":"20240322","item0":"-1.47","item1":"-3.13"},{"date":"20240325","item0":"-1.91","item1":"-4.37"},{"date":"20240326","item0":"0.44","item1":"-0.24"},{"date":"20240327","item0":"-2.81","item1":"-0.65"},{"date":"20240328","item0":"0.95","item1":"1.92"},{"date":"20240329","item0":"0.63","item1":"-0.94"},{"date":"20240401","item0":"2.97","item1":"3.44"},{"date":"20240402","item0":"-0.62","item1":"-1.43"},{"date":"20240403","item0":"-1.08","item1":"0.81"},{"date":"20240408","item0":"-1.81","item1":"-8.02"},{"date":"20240409","item0":"1.14","item1":"6.83"},{"date":"20240410","item0":"-2.06","item1":"-4.34"},{"date":"20240411","item0":"-0.44","item1":"-0.80"},{"date":"20240412","item0":"-1.08","item1":"0.62"},{"date":"20240415","item0":"1.85","item1":"-8.05"},{"date":"20240416","item0":"-1.97","item1":"-8.09"},{"date":"20240417","item0":"2.11","item1":"8.29"},{"date":"20240418","item0":"-0.55","item1":"-2.69"}]
||
您尚未登录,请登录后再添加自选股!